Article Details
Retrieved on: 2024-02-24 16:48:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2 ...
Article found on: www.americanbankingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here